| Larry Leonard Myers Jr, MD | |
|
5323 Harry Hines Blvd, Dallas, TX 75390-7208 | |
| (214) 645-0624 | |
| (214) 645-0078 |
| Full Name | Larry Leonard Myers Jr |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 32 Years |
| Location | 5323 Harry Hines Blvd, Dallas, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285603035 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | L0442 (Texas) | Secondary |
| 207YX0007X | Otolaryngology - Plastic Surgery Within The Head & Neck | L0442 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ut Southwestern University Hospital - William P. Clements Jr. | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Texas Southwestern Medical Center | 0648188250 | 2588 |
News Archive
A potential COVID-19 vaccine developed at Flinders University has commenced human trials in South Australia.
In the Sept. 9, 2010 issue of Neuron, Neurogenetic Pharmaceuticals, Inc. (NGP) reports proof of concept studies that show its proprietary compound, NGP 555, is effective in preventing the amyloid pathology of Alzheimer's disease (AD) in a transgenic mouse model.
People with a high polygenic risk score for colorectal cancer could benefit more at preventing the disease by leading healthy lifestyles than those at lower genetic risk, according to a study by Vanderbilt researchers published in the April issue of The American Journal of Clinical Nutrition.
Researchers at St. Michael's Hospital have found more evidence of the benefits of home dialysis for patients with kidney failure.
› Verified 2 days ago
| Entity Name | University Of Texas Southwestern Medical Center At Dallas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
A potential COVID-19 vaccine developed at Flinders University has commenced human trials in South Australia.
In the Sept. 9, 2010 issue of Neuron, Neurogenetic Pharmaceuticals, Inc. (NGP) reports proof of concept studies that show its proprietary compound, NGP 555, is effective in preventing the amyloid pathology of Alzheimer's disease (AD) in a transgenic mouse model.
People with a high polygenic risk score for colorectal cancer could benefit more at preventing the disease by leading healthy lifestyles than those at lower genetic risk, according to a study by Vanderbilt researchers published in the April issue of The American Journal of Clinical Nutrition.
Researchers at St. Michael's Hospital have found more evidence of the benefits of home dialysis for patients with kidney failure.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Larry Leonard Myers Jr, MD 5323 Harry Hines Blvd, Dallas, TX 75390-7201 Ph: (214) 648-3111 | Larry Leonard Myers Jr, MD 5323 Harry Hines Blvd, Dallas, TX 75390-7208 Ph: (214) 645-0624 |
News Archive
A potential COVID-19 vaccine developed at Flinders University has commenced human trials in South Australia.
In the Sept. 9, 2010 issue of Neuron, Neurogenetic Pharmaceuticals, Inc. (NGP) reports proof of concept studies that show its proprietary compound, NGP 555, is effective in preventing the amyloid pathology of Alzheimer's disease (AD) in a transgenic mouse model.
People with a high polygenic risk score for colorectal cancer could benefit more at preventing the disease by leading healthy lifestyles than those at lower genetic risk, according to a study by Vanderbilt researchers published in the April issue of The American Journal of Clinical Nutrition.
Researchers at St. Michael's Hospital have found more evidence of the benefits of home dialysis for patients with kidney failure.
› Verified 2 days ago
Dr. Anthony Michael Tolisano, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3102 | |
Presley M. Mock, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8440 Walnut Hill Ln, Ste 500, Dallas, TX 75231 Phone: 214-345-1491 Fax: 214-345-5708 | |
Dr. Jane Farrar Admire, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 7777 Forest Ln, Suite C-100, Dallas, TX 75230 Phone: 972-566-4848 | |
Chung-en Huang, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3430 W Wheatland Rd Ste 209, Dallas, TX 75237 Phone: 972-780-1496 Fax: 972-709-1496 | |
Dr. Seckin Omer Ulualp, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1935 Medical District Dr, Dallas, TX 75235 Phone: 214-456-2905 | |
Dr. Kenneth H Lee, M.D., PH.D Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd., Ut Soutwestern Otolaryngology, Dallas, TX 45229 Phone: 214-648-2972 Fax: 214-648-9122 | |
Jacob Boston Hunter, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-8898 Fax: 214-645-8894 |